Dextromethorphan Hydrobromide and Quinidine Sulphate
- Product NDC
- 63304-650
- Requested package NDC
- 63304-650-60
- 11-digit product format
- 633040650
- Labeler code
- 63304
- Product ID
- 63304-650_5617af8d-e7b7-1c2c-e063-6294a90a7486
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Dextromethorphan Hydrobromide and Quinidine Sulphate
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Application
- ANDA204196
- Marketing category
- ANDA
- Marketing start
- 2026-07-30
- Substance
- DEXTROMETHORPHAN HYDROBROMIDE; QUINIDINE SULFATE
- Active strength
- 20; 10 mg/1; mg/1
- Pharmacologic classes
- Antiarrhythmic [EPC], Cytochrome P450 2D6 Inhibitor [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A204196-001 | DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE | DEXTROMETHORPHAN HYDROBROMIDE; QUINIDINE SULFATE | 20MG;10MG | CAPSULE / ORAL | AB | 2026-06-03 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A204196-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A204196-001 | DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE | 20MG;10MG | CAPSULE / ORAL | AB | 2026-06-03 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A204196-001 | DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE | 20MG;10MG | CAPSULE / ORAL | AB | 2026-06-03 | caaa826d4ba7… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A204196-001 | DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE | 20MG;10MG | CAPSULE / ORAL | AB | 2026-06-03 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A204196-001 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A204196-001 | AB | 1 | caaa826d4ba7… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A204196-001 | AB | 1 | a50c72e98297… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Dextromethorphan Hydrobromide and Quinidine Sulphate
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| DEXTROMETHORPHAN HYDROBROMIDE | 20 mg/1 |
| QUINIDINE SULFATE | 10 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 9D2RTI9KYH | Internal UNII lookup |
| J13S2394HE | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1040054 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 92b54ac4-594e-47b8-a4d3-394a29b425f3 | Available on FDA.report |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dextromethorphan Hydrobromide and Quinidine Sulphate | DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULPHATE | Golden State Medical Supply, Inc. | 583de7bd-9b82-5e55-e063-6294a90a0bdf | 2026-08-04 | Warnings, Adverse reactions | 204196 ANDA204196 |
| Dextromethorphan Hydrobromide and Quinidine Sulphate | DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULPHATE | Sun Pharmaceutical Industries, Inc. | 92b54ac4-594e-47b8-a4d3-394a29b425f3 | 2026-07-08 | Warnings, Adverse reactions | 204196 ANDA204196 63304-650-60 63304-650 63304065060 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 63304-650-60 | 63304065060 | 60 CAPSULE in 1 BOTTLE (63304-650-60) | 60 capsule | 2026-07-30 | No | No | Current |